← All organizations

Arbor Pharmaceuticals

For profitWebsite ↗

Also known as: Arbor Pharmaceuticals | Arbor Pharmaceuticals, Inc. | Arbor Pharmaceuticals, LLC | Arbor Pharmaceuticals, LLC. | ARBOR PHARMS INC | ARBOR PHARMS LLC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Jan 31, 2022

Acquired by Azurity on Aug 24, 2021

Timeline

2000s

Jun 23, 2005
hydralazine— Marketing Organization
Jan 1, 2006
Arbor Pharmaceuticals— Founded

2010s

Feb 25, 2011
azilsartan— NDA Secondary Org
Jan 1, 2015
XenoPort, Inc.— Acquired

2020s

Aug 24, 2021
Azurity— Acquired By

Drugs by trial phase (28 distinct, 42 trials)

Phase 4 (2 own, 1 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 13 via acquisition)

Phase 1 (4 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (14)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

XenoPort, Inc.

Recent trials (22)

NCT06247488Lead sponsorPhase 4Jan 31, 2022
NCT04222062CollaboratorPhase 2Feb 1, 2020
NCT03659929Study directorPhase 3Sep 13, 2018
NCT03659929Lead sponsorPhase 3Sep 13, 2018
NCT02522208Lead sponsorPhase 1Sep 1, 2015
NCT02522208Study chairPhase 1Sep 1, 2015
NCT02235909Lead sponsorPhase 3Dec 1, 2014
NCT02723669Study directorPhase 1Apr 1, 2014
NCT02723669Lead sponsorPhase 1Apr 1, 2014
NCT02049164Lead sponsorPhase 2Jan 1, 2014
NCT01986062Lead sponsorPhase 4Dec 1, 2013
NCT02044341Lead sponsorPhase 3Dec 1, 2013
NCT02044341Study chairPhase 3Dec 1, 2013
NCT01986062Study directorPhase 4Dec 1, 2013
NCT02074007Lead sponsorPhase 3Dec 1, 2013

Details

Founded: Atlanta, GA, US Jan 1, 2006
Last known activity: Jan 31, 2022